• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发全因子设计评估液相色谱技术以在存在干粉吸入剂中特定杂质和降解杂质的情况下测定布地奈德和富马酸福莫特罗二水合物的独特研究。

Unique Research for Developing a Full Factorial Design Evaluated Liquid Chromatography Technique for Estimating Budesonide and Formoterol Fumarate Dihydrate in the Presence of Specified and Degradation Impurities in Dry Powder Inhalation.

作者信息

Bandaru Lova Gani Raju, Konduru Naresh, Kowtharapu Leela Prasad, Gundla Rambabu, Kanuparthy Phani Raja, Katari Naresh Kumar

机构信息

Department of Chemistry, GITAM School of Science, GITAM Deemed to Be University, Hyderabad, India.

出版信息

Biomed Chromatogr. 2025 Feb;39(2):e6062. doi: 10.1002/bmc.6062.

DOI:10.1002/bmc.6062
PMID:39790086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11718425/
Abstract

A simple LC method has been developed and validated for estimating budesonide (epimer B + A) and formoterol fumarate dihydrate in dry powder inhalation. The development results of this study make it very significant. The degradation and process impurities in EP and ChP were identified in addition to budesonide and formoterol fumarate. As of yet, no one has reported all impurities using a single method. It is a unique research because it analyzes APSD (Aerodynamic Particle Size Distribution), DDU (Delivered Dose Uniformity), BU (Blend Uniformity), Assay, and cleaning test samples. It enhances the quality of medicine and separates all organic impurities and isomers through a suitable stationary phase (YMC-Pack Pro C18, 150 × 4.6 mm × 3 μm). We optimized the chromatographic conditions: Injection volume was 20 μL, and flow rate was 1.0 mL/min. The wavelength was optimized at 220 nm. After experimental and validation results. An example is A, which contains sodium dihydrogen orthophosphate monohydrate, sodium 1-decane sulfonate, adjusted pH 3.0, and acetonitrile at a ratio of 80:20 (v/v), and B, which contains pH 3.0 buffer and acetonitrile at a ratio of 20:80 (v/v) respectively. In addition to being optimized, the test method was validated according to ICH Q2(R2).

摘要

已开发并验证了一种简单的液相色谱法,用于测定干粉吸入剂中的布地奈德(差向异构体B + A)和富马酸福莫特罗二水合物。本研究的开发结果具有重要意义。除了布地奈德和富马酸福莫特罗外,还鉴定了欧洲药典和中国药典中的降解产物和工艺杂质。迄今为止,尚未有人用单一方法报道所有杂质。这是一项独特的研究,因为它分析了空气动力学粒径分布(APSD)、递送剂量均匀性(DDU)、混合均匀性(BU)、含量测定以及清洁测试样品。它提高了药品质量,并通过合适的固定相(YMC-Pack Pro C18,150×4.6 mm×3μm)分离所有有机杂质和异构体。我们优化了色谱条件:进样体积为20μL,流速为1.0 mL/min。波长优化为220 nm。经过实验和验证结果。例如,流动相A含有一水合磷酸二氢钠、1-癸烷磺酸钠,pH值调至3.0,乙腈比例为80:20(v/v),流动相B含有pH值为3.0的缓冲液和乙腈,比例分别为20:80(v/v)。除了进行优化外,该测试方法还根据ICH Q2(R2)进行了验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/5d2c43933ad5/BMC-39-e6062-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/346d6d05e4ba/BMC-39-e6062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/3cba29dd4305/BMC-39-e6062-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/1b721c08d11e/BMC-39-e6062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/e87e86611e7e/BMC-39-e6062-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/5a6e219bba6e/BMC-39-e6062-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/b2cb33882134/BMC-39-e6062-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/81665d850fb1/BMC-39-e6062-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/a09325a9ab54/BMC-39-e6062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/0731324da1ba/BMC-39-e6062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/a4141d81ded4/BMC-39-e6062-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/5d2c43933ad5/BMC-39-e6062-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/346d6d05e4ba/BMC-39-e6062-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/3cba29dd4305/BMC-39-e6062-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/1b721c08d11e/BMC-39-e6062-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/e87e86611e7e/BMC-39-e6062-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/5a6e219bba6e/BMC-39-e6062-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/b2cb33882134/BMC-39-e6062-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/81665d850fb1/BMC-39-e6062-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/a09325a9ab54/BMC-39-e6062-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/0731324da1ba/BMC-39-e6062-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/a4141d81ded4/BMC-39-e6062-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c74c/11718425/5d2c43933ad5/BMC-39-e6062-g005.jpg

相似文献

1
Unique Research for Developing a Full Factorial Design Evaluated Liquid Chromatography Technique for Estimating Budesonide and Formoterol Fumarate Dihydrate in the Presence of Specified and Degradation Impurities in Dry Powder Inhalation.开发全因子设计评估液相色谱技术以在存在干粉吸入剂中特定杂质和降解杂质的情况下测定布地奈德和富马酸福莫特罗二水合物的独特研究。
Biomed Chromatogr. 2025 Feb;39(2):e6062. doi: 10.1002/bmc.6062.
2
Simultaneous Determination of Formoterol Fumarate and Budesonide Epimers in Metered Dose Inhaler Using Ion-Pair Chromatography.采用离子对色谱法同时测定定量吸入器中富马酸福莫特罗和布地奈德差向异构体
J Chromatogr Sci. 2017 Nov 1;55(10):1013-1020. doi: 10.1093/chromsci/bmx067.
3
High performance liquid chromatography assay method for simultaneous quantitation of formoterol and budesonide in Symbicort Turbuhaler.用于同时定量信必可都保中福莫特罗和布地奈德的高效液相色谱测定法。
J Pharm Biomed Anal. 2006 Apr 11;41(1):325-8. doi: 10.1016/j.jpba.2005.11.015. Epub 2005 Dec 27.
4
Pharmaceutical equivalence of the combination formulation of budesonide and formoterol in a single capsule with a dry powder inhaler.布地奈德/福莫特罗单一胶囊干粉吸入剂中联合制剂的药学等效性。
J Bras Pneumol. 2012 Nov-Dec;38(6):748-56. doi: 10.1590/s1806-37132012000600010.
5
A validated stability-indicating reversed-phase-HPLC method for dipyridamole in the presence of degradation products and its process-related impurities in pharmaceutical dosage forms.在药物制剂中存在降解产物和其工艺相关杂质的情况下,对双嘧达莫进行稳定性指示的反相高效液相色谱法的验证。
Biomed Chromatogr. 2022 Jan;36(1):e5247. doi: 10.1002/bmc.5247. Epub 2021 Oct 21.
6
Favipiravir (SARS-CoV-2) degradation impurities: Identification and route of degradation mechanism in the finished solid dosage form using LC/LC-MS method.非那韦(SARS-CoV-2)降解杂质:使用 LC/LC-MS 方法在固体制剂中鉴定和降解途径。
Biomed Chromatogr. 2022 Jun;36(6):e5363. doi: 10.1002/bmc.5363. Epub 2022 Apr 6.
7
Effect of Flow Rate on In Vitro Aerodynamic Performance of NEXThaler(®) in Comparison with Diskus(®) and Turbohaler(®) Dry Powder Inhalers.流速对NEXThaler(®)与Diskus(®)和Turbohaler(®)干粉吸入器体外空气动力学性能的影响比较
J Aerosol Med Pulm Drug Deliv. 2016 Apr;29(2):167-78. doi: 10.1089/jamp.2015.1220. Epub 2015 Sep 10.
8
Pharmacokinetics of Co-Suspension Delivery Technology Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate (BGF MDI) and Budesonide/Formoterol Fumarate Dihydrate (BFF MDI) Fixed-Dose Combinations Compared With an Active Control: A Phase 1, Randomized, Single-Dose, Crossover Study in Healthy Adults.布地奈德/格隆溴铵/富马酸福莫特罗水合物(BGF MDI)和布地奈德/富马酸福莫特罗水合物(BFF MDI)固定剂量组合的共悬浮递送技术的药代动力学与阳性对照相比:一项在健康成年人中进行的 1 期、随机、单剂量、交叉研究。
Clin Pharmacol Drug Dev. 2019 Feb;8(2):223-233. doi: 10.1002/cpdd.585. Epub 2018 Jun 14.
9
Effect of inhaled budesonide/formoterol fumarate dihydrate delivered via two different devices on lung function in patients with COPD and low peak inspiratory flow.两种不同装置吸入布地奈德/福莫特罗富马酸二水合物对 COPD 及低峰吸气流速患者肺功能的影响。
Ther Adv Respir Dis. 2022 Jan-Dec;16:17534666221107312. doi: 10.1177/17534666221107312.
10
Validation of a RP-HPLC method for the assay of formoterol and its related substances in formoterol fumarate dihydrate drug substance.反相高效液相色谱法测定富马酸福莫特罗二水合物原料药中福莫特罗及其有关物质的方法验证
J Pharm Biomed Anal. 2003 Dec 4;33(5):935-45. doi: 10.1016/s0731-7085(03)00425-4.

本文引用的文献

1
Development, evaluation of critical method variables and stability assessment using a Box-Behnken design for the determination of organic impurities in a pharmaceutical dosage form of a centrally acting muscle relaxant drug chlorzoxazone.采用 Box-Behnken 设计开发、评估关键方法变量并评估稳定性,以测定中枢作用肌肉松弛药物氯唑沙宗的药物制剂中的有机杂质。
Biomed Chromatogr. 2024 Nov;38(11):e6001. doi: 10.1002/bmc.6001. Epub 2024 Sep 4.
2
An effective and stability-indicating method development and optimization utilizing the Box-Behnken design for the simultaneous determination of acetaminophen, caffeine, and aspirin in tablet formulation.利用Box-Behnken设计开发并优化一种有效且具有稳定性指示作用的方法,用于同时测定片剂制剂中的对乙酰氨基酚、咖啡因和阿司匹林。
Biomed Chromatogr. 2023 Apr;37(4):e5585. doi: 10.1002/bmc.5585. Epub 2023 Feb 11.
3
Unique Quality by Design Approach for Developing HPLC and LC-MS Method for Estimation of Process and Degradation Impurities in Pibrentasvir, Antiviral Agent for Hepatitis C.用于开发高效液相色谱法(HPLC)和液相色谱-质谱联用(LC-MS)法的独特设计质量方法,用于评估抗丙型肝炎病毒药物比布伦特斯韦中的工艺杂质和降解杂质。
ACS Omega. 2022 Dec 15;7(51):47650-47661. doi: 10.1021/acsomega.2c04617. eCollection 2022 Dec 27.
4
Unique liquid chromatography technique for the determination of mirabegron in the presence of polymers; robustness by Design Expert in the light of Quality by Design.用于在聚合物存在下测定米拉贝隆的独特液相色谱技术;通过设计专家在质量源于设计的指导下进行稳健性研究。
Biomed Chromatogr. 2022 Oct;36(10):e5449. doi: 10.1002/bmc.5449. Epub 2022 Jul 27.
5
Quantitative Determination of Related Substances in Formoterol Fumarate and Tiotropium in Tiomate Transcaps Dry Powder Inhaler.噻托溴铵/富马酸福莫特罗干粉吸入剂中富马酸福莫特罗和噻托溴铵相关物质的定量测定。
Turk J Pharm Sci. 2022 Feb 28;19(1):35-47. doi: 10.4274/tjps.galenos.2021.77177.
6
Determination of progesterone (steroid drug) in the semi-solid dosage form (vaginal gel) using a stability-indicating method by RP-HPLC/PDA detector.采用RP-HPLC/PDA检测器的稳定性指示方法测定半固体剂型(阴道凝胶)中的孕酮(甾体药物)。
Biomed Chromatogr. 2022 Jan;36(1):e5246. doi: 10.1002/bmc.5246. Epub 2021 Oct 8.
7
Validation of a HPLC-UV method for the quantification of budesonide in skin layers.HPLC-UV 法测定皮肤层中布地奈德含量的验证。
J Chromatogr B Analyt Technol Biomed Life Sci. 2021 Feb 1;1164:122512. doi: 10.1016/j.jchromb.2020.122512. Epub 2020 Dec 24.
8
Ultra high-performance liquid chromatography method development for separation of formoterol, budesonide, and related substances using an analytical quality by design approach.采用分析质量源于设计方法开发分离福莫特罗、布地奈德和相关物质的超高效液相色谱法。
J Pharm Biomed Anal. 2021 Jan 30;193:113729. doi: 10.1016/j.jpba.2020.113729. Epub 2020 Oct 29.
9
Multiple analytical methods for determination of formoterol and glycopyrronium simultaneously in their novel combined metered dose inhaler.用于同时测定新型复方定量吸入器中福莫特罗和格隆溴铵的多种分析方法。
BMC Chem. 2019 Jun 10;13(1):75. doi: 10.1186/s13065-019-0592-9. eCollection 2019 Dec.
10
Pharmacogenetics of inhaled long-acting beta2-agonists in asthma: A systematic review.吸入长效β2-激动剂在哮喘中的药物遗传学:系统评价。
Pediatr Allergy Immunol. 2018 Nov;29(7):705-714. doi: 10.1111/pai.12956. Epub 2018 Aug 12.